Q&A (Coffee Part 2): Is coffee a health elixir or a hidden risk?

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Take-Home Messages 🔑

 ☕Introduction

Despite its inherently bitter taste—typically an aversive flavour—coffee ranks among the most widely consumed beverages globally (1, 2). This paradox is partly explained by emotional and habitual drivers of consumption, which often outweigh purely functional motives (3). Given coffee’s popularity, it is essential to understand its health benefits and risks, as this knowledge should ultimately guide consumption choices.

Historically, coffee has been both praised for its stimulating effects and criticised for its potential health risks. Scientific perspectives have shifted from broad scepticism to a more nuanced appreciation of coffee’s complex health impacts (4). Far beyond a simple caffeine delivery system, coffee is a rich source of antioxidants, prebiotics and bioactive compounds—such as cafestol and chlorogenic acids—that may influence metabolism, mental performance and disease risk.

In Part 1 I explored the origins, types and chemical composition of coffee, including its key bioactive components and preparation methods. Here, I synthesise the latest research on coffee’s potential health benefits and risks, offering practical guidance on how to enjoy coffee in a way that supports overall well-being without compromising health.

Health benefits

Research on coffee and health is complicated by numerous confounders, making it difficult to isolate coffee’s effects. Its health impact depends on factors such as type, quantity and preparation method. Even within the same individual, consumption can vary—one cup may be black, another with cream or sugar; one might be instant or decaf, another brewed from a high-end machine at work or purchased at a café—yet such detail is rarely captured in research. Complicating matters are intake timing and individual biological differences, including genetic makeup (5, 6). The psychosocial context of coffee consumption—such as drinking it in a relaxed social setting versus under work-related stress often coupled with poor sleep—may also modulate its physiological effects, yet this nuance remains largely unexplored (7). Moreover, coffee might replace less healthy beverages such as sugar sweetened beverages (8), further complicating the interpretation of results. Socioeconomic status is positively associated with coffee intake, with higher-income groups consuming more coffee (9). In nationally representative U.S. data (NHANES 2011–2016), coffee consumption was most prevalent among higher-income adults and was associated with higher diet quality, as reflected by greater Healthy Eating Index scores and more favourable nutrient profiles, including lower added sugar intake (9). This underscores the importance of distinguishing the effects of coffee per se from correlated socioeconomic and lifestyle factors, such as access to healthcare, food security, dietary diversity and overall diet quality. Additionally, coffee drinkers often differ from non-drinkers in lifestyle behaviours—such as smoking (2), alcohol use, diet quality and physical activity—that can distort associations with health outcomes. Reverse causation is also a possibility—that is, instead of coffee influencing health, individuals with certain health conditions may reduce or avoid coffee consumption, thereby distorting the observed associations.

Cognitive performance

Cross-sectional data from 2,254 adults aged ≥60 years in NHANES 2011–2014, assessing cognitive performance (CERAD, Animal Fluency, DSST) in relation to coffee and caffeine intake, and incorporating Mendelian randomisation (MR), protein quantitative trait locus analysis and protein–protein interaction networks to explore potential causal pathways involving alkaline phosphatase (ALP). Higher coffee consumption (≥480 g/day) was associated with lower odds of poor cognitive performance, with evidence suggesting that coffee and caffeine may exert protective effects partly mediated through ALP, although MR analyses indicated complex and potentially divergent associations with cognitive outcomes (10).

Physical performance 💪

Caffeine is widely recognised as an ergogenic aid i.e. it can enhance physical or mental performance. Moderate doses (3–6 mg/kg body weight) have been shown to provide small but significant improvements in endurance performance, including power output and time-trial results (11, 12) and enhances volleyball-specific skills (13). Self-selected motivational music and caffeine intake independently enhanced anaerobic performance in female handball players, with the combined use showing the greatest—though not statistically significant—improvement (14). However, responses vary depending on genetics (e.g., CYP1A2 gene) (15), as well as context and population. Caffeine benefits some athletes but has shown no improvements in older adults or in certain high-intensity workouts including CrossFit training or in basketball players (16-18). In a systematic review and meta-analysis of 12 studies (random-effects model, 230 participants), caffeine ingestion enhanced movement velocity and power output during resistance exercises, with stronger effects in men, low habitual caffeine consumers and lower-body exercises (19).

5 mg/kg caffeine dose—within National Collegiate Athletic Association legal limits—did not improve squat or countermovement vertical jump height in trained collegiate athletes (20). Men outperformed women, but caffeine had no additional effect across sexes. While performance improved slightly between trials (likely due to warm-up effects), no ergogenic benefit from caffeine was observed. These findings align with growing evidence that caffeine's impact is highly individual and may depend on dose, habituation and psychological factors—including the mere expectation of consuming caffeine (21).

In a randomised, triple-blind, placebo-controlled crossover trial, acute caffeine ingestion (3 mg/kg) improved muscular strength and endurance in resistance-trained men and women (22). They also examined whether the CYP1A2 genotype modified the ergogenic response; while no significant genotype interaction was observed, performance improvements were greatest in AA, intermediate in AC and smallest in CC carriers (22).

All-cause mortality and non-communicable diseases

For all-cause mortality, an umbrella review found that coffee consumption was associated with a 17% reduction in risk at three to four cups per day compared to none (4). Higher coffee consumption is associated with reduced all-cause mortality among U.S. adults, but these benefits are limited to black coffee or coffee with low added sugar and saturated fat (23). Drinking coffee primarily in the morning is associated with a lower risk of all-cause and cardiovascular mortality compared to drinking it throughout the day or not at all (24). In Japanese older adults, higher caffeine and coffee consumption was linked to reduced disability and mortality risk, while green tea showed no such association (25).

A prospective UK Biobank study of over 60,000 participants examined how habitual coffee intake influences the progression of non-communicable diseases to multimorbidity and mortality. Drinking fewer than three cups of coffee per day was linked to a reduced risk of developing a first non-communicable diseases and progressing to multimorbidity, while consuming more than five cups daily increased the risk of multimorbidity and death. The harmful effects of high coffee intake were strongest among individuals with slower caffeine metabolism, highlighting the role of genetic susceptibility in disease trajectories.

Insulin resistance, type 2 diabetes and metabolic syndrome

The table below summarises the evidence linking coffee consumption to type 2 diabetes, insulin resistance and metabolic syndrome, organised according to study design to reflect the strength of evidence. Overall, findings consistently suggest that moderate coffee intake—particularly when consumed without added sugar or cream—is associated with improved metabolic outcomes, although relationships are often non-linear and influenced by factors such as dose, timing, sex and preparation. While cohort studies and meta-analyses support protective associations, emerging evidence from Mendelian randomisation and experimental studies highlights potential causal pathways, alongside important context-specific variability.

Table: Coffee intake and metabolic health outcomes by study design

IR, insulin resistance; MR, Mendelian randomisation; OR, odds ratio

A randomised pilot trial showed that coffee roast level, timing of intake and carbohydrate co-ingestion influence postprandial glucose responses, with pre-meal coffee producing higher glucose peaks and medium-roast coffee consumed with carbohydrates lowering overall glucose exposure (34). Additionally, Brazilian coffee has been shown to enhance the antidiabetic and liver-protective effects of metformin through synergistic antioxidant and enzyme-inhibitory actions, suggesting potential therapeutic value in combining coffee with metformin for managing type 2 diabetes (35).

Cardiovascular health🫀

Coffee consumption appears to have varied effects on cardiovascular health.

Lipids and blood coagulation

Chlorogenic acids in coffee may help reduce atherosclerosis by inhibiting mechanisms that harden arteries. Coffee consumption has a dual effect on serum lipid profiles: it is associated with increased total and LDL cholesterol levels, while showing complex, gender-specific and non-linear relationships with HDL cholesterol and triglycerides (36). In over 27,000 Taiwanese adults coffee consumption was associated with lower risks of hypertriglyceridaemia and low HDL cholesterol (32).

Moderate coffee intake has been shown to inhibit platelet aggregation, particularly when stimulated by collagen and arachidonic acid (37). This effect is attributed to coffee’s phenolic compounds rather than caffeine. Coffee consumption does not alter fibrinogen levels, with no observed association between coffee intake and fibrinolytic markers (38). The impact of coffee on endothelial function appears dose-dependent: moderate consumption may improve endothelial function due to antioxidant properties, while acute intake of caffeinated coffee may temporarily impair it (39). Epidemiological studies have also found that coffee consumption is associated with a reduced risk of venous thrombosis, potentially mediated by reductions in von Willebrand factor and factor VIII levels (38).

Oxidative stress and inflammation

Consumption, primarily attributable to the substantial antioxidant content of coffee, exerts a beneficial effect by reducing biomarkers associated with oxidative stress and inflammation (40). Sustained or long-term consumption (exceeding four weeks) confers greater protective benefits than short-term intake (40). A systematic review and meta-analysis of 11 cross-sectional studies involving 66,691 adults found a linear inverse association between coffee consumption and C-reactive protein (CRP) levels, with higher intake linked to progressively lower CRP, and suggested that factors such as gender and smoking adjustment may modify this relationship (41).

Heart rate

A meta-analysis of six randomised control trials found that consuming 3–6 cups of coffee daily for 2–24 weeks had no effect on resting heart rate, suggesting no impact in healthy or mildly at-risk individuals (42). However, a randomised crossover trial showed that Turkish coffee reduced heart rate in healthy young women, indicating possible acute effects (43).

Endothelial function and atherosclerosis

In a meta-analysis of 19 randomised controlled trials, coffee-related bioactive components showed distinct effects on endothelial function: chlorogenic acids (CGAs), both acutely and with longer-term intake, improved flow-mediated vasodilation (FMD)—especially when consumed in coffee beverages—while caffeine had no effect and hydroxyhydroquinone (HHQ) reduced FMD, supporting the role of moderate CGA-rich coffee consumption in promoting vascular health and lowering cardiovascular risk (44).

A combined observational analysis and Mendelian randomisation (MR) were conducted in 24,835 participants from the Swedish CardioPulmonary bioImage Study, with replication in the UK Biobank, to examine associations between coffee intake and subclinical atherosclerosis measured by segment involvement score (SIS), coronary artery calcium score (CACS) and carotid plaque (45). Observational analyses showed no association between self-reported coffee intake and atherosclerosis markers, whereas one-sample and two-sample MR analyses indicated that genetically predicted higher coffee consumption was associated with increased SIS, particularly among frequent coffee drinkers (45). Genetic variants—specifically single nucleotide polymorphisms (SNPs) in the aryl hydrocarbon receptor (AHR) gene and the cytochrome P450 1A1/1A2 (CYP1A1/CYP1A2) gene cluster, which are involved in caffeine metabolism and detoxification—were associated with SIS, with integrative metabolomic and proteomic analyses further implicating lipid metabolism (triglycerides, phospholipids, free cholesterol) and inflammatory pathways (DLK1, IL1RL2, CCL17) (45).

Hypertention

A systematic review of 25 observational studies found that higher coffee intake is linked to reduced hypertension risk, though results varied by region, sex and sample size (46).

Cardiovascular disease and mortality

Moderate coffee consumption is associated with lower risks of heart disease and stroke.

•          One systematic review with meta-analysis found reduced cardiovascular disease (CVD)-related mortality in men (HR: 0.63), but not in women (HR: 0.78) (47).

•          An umbrella review of 11 meta-analyses (12 million individuals) showed up to 4 cups daily reduced stroke risk by 12% and modestly lowered dementia risk. However, heavy intake may increase CVD risk (48).

•          Among diabetics, daily coffee and tea intake was linked to reduced CVD and mortality risk, though evidence certainty was moderate-to-low (49).

•          National Health and Nutrition Examination Survey data revealed that various coffee types—including caffeinated, sugar-free, full-fat and fat-free—were associated with reduced all-cause and cardiovascular mortality in adults with prediabetes. Caffeinated coffee lowered CVD mortality, while full-fat coffee was linked to lower CVD prevalence (50).

·             In a large cohort study from the HUNT and Tromsø surveys, drinking 1–2 cups of coffee per day was linked to lower risk of venous thromboembolism—especially pulmonary embolism—suggesting a non-linear protective association consistent across sexes (51).

·             The DECAF randomised clinical trial of 200 patients with atrial fibrillation found that consuming about one cup of caffeinated coffee daily after cardioversion reduced recurrence of atrial fibrillation or atrial flutter compared with abstinence, lowering risk by 39% (52). No differences in adverse events were observed, challenging the belief that caffeinated coffee is proarrhythmic (52).

·             In patients with heart failure, consuming one to three cups of coffee per day was not associated with increased all-cause mortality, based on NHANES data (53). However, intake of four or more cups per day was linked to a higher mortality risk, indicating that high coffee consumption may be harmful in this population (53).

Cancer 🧬

Evidence on coffee and cancer risk varies by cancer type and study design, with largely protective associations observed for liver and endometrial cancers, while findings for others remain inconsistent or context-dependent.

Table: Coffee consumption and cancer risk by cancer type

SCC, squamous cell carcinoma

Liver diseases

A meta-analysis of nine studies found that drinking two additional cups of coffee per day is associated with a lower risk of cirrhosis and cirrhosis-related death, suggesting a dose-dependent protective effect of coffee (64). Coffee’s bioactive compounds may offer protective effects against metabolic dysfunction-associated steatotic liver disease (MASLD) by modulating inflammation and oxidative stress along the gut–liver axis, with emerging evidence highlighting a key role for the gut microbiome in this interplay (65). In a large prospective cohort study (n=185,437), higher intake of unsweetened—particularly caffeinated—coffee was associated with a lower risk of metabolic dysfunction-associated steatotic liver disease, while sweetened coffee showed no association (66). These relationships were independent of genetic predisposition related to gut microbiota and MASLD risk (66).

Fracture risk and osteoporosis 🦴

While earlier reviews (4), suggested increased fracture risk in women due to caffeine-related calcium loss, a more recent and comprehensive meta-analysis (67) involving over 560,000 participants found that regular coffee and tea consumption may actually reduce osteoporosis risk. These protective effects appear stronger with higher intake and may be influenced by factors such as milk addition, sex and coffee preparation method.

Contradictory findings in the literature may be explained by gene–environment interactions. In a 3-year longitudinal analysis, women consuming more than 300 mg caffeine per day experienced greater spinal bone loss than those with lower intakes, an effect that was most pronounced among women with the TT vitamin D receptor (VDR) genotype (68).

Neurodegenerative diseases 🧠

Emerging evidence suggests that coffee consumption, particularly caffeinated and unsweetened varieties, may play a role in reducing the risk and progression of neurodegenerative diseases. A large UK Biobank study (69) involving 204,847 participants over nine years found that consuming ≥3 cups/day of unsweetened, caffeinated coffee was linked to reduced risks of Alzheimer’s and related dementias (HR: 0.75), Parkinson’s disease (HR: 0.71) and neurodegenerative mortality (HR: 0.67). No protective associations were observed for decaffeinated or sweetened coffee, suggesting neuroprotective effects may be specific to caffeinated, unsweetened varieties. A systematic review and meta-analysis (70) reported potential cognitive benefits from long-term chlorogenic acid intake, though current randomised controlled trials show no effects, underscoring the need for more rigorous studies. Another systematic review found that moderate caffeine intake may slow Alzheimer’s progression in individuals with mild cognitive impairment, with effects influenced by dose, genetics and timing of exposure (71). A study including 131 821 participants (86 606 women from the Nurses’ Health Study and 45 215 men from the Health Professionals Follow-up Study) with up to 43 years of follow-up. During this period, 11 033 cases of dementia were documented (72). This study found that higher intake of caffeinated coffee and tea was linked to a lower risk of dementia and modestly better cognitive outcomes, while decaffeinated coffee showed no such benefit (72). The strongest associations were observed at moderate consumption levels—about 2 to 3 cups of caffeinated coffee or 1 to 2 cups of tea per day (72).

Gout🔬

Higher coffee intake is linked to reduced gout risk, particularly in men (73) but also in women (74), with a dose-dependent effect—≥4 cups/day offering the greatest protection. A Mendelian randomisation study supports this inverse association (75), but the interpretation is limited by methodological concerns. The genetic variants used explain only a small proportion of coffee intake variability, which may undermine causal inference (76).

Coffee, particularly caffeinated, may lower serum uric acid—a key gout risk factor—via effects on xanthine oxidase and uric acid clearance. In a within-participant trial (77), decaffeinated coffee reduced serum uric acid in hyperuricaemic men, while caffeinated coffee increased uric acid and xanthine oxidase activity in normouricaemic individuals, with no change in clearance. These effects likely stem from polyphenols and chlorogenic acids, which may enhance insulin sensitivity and uric acid excretion (78, 79). Caffeine, structurally similar to allopurinol, may inhibit xanthine oxidase, though high acute doses can transiently raise uric acid.

Tea does not show the same protective association (80). Sugary drinks (81) and fructose-sweetened (high fructose corn syrup) beverages(82), in contrast, are strongly associated with increased gout risk.

⚠️ Important Considerations

People who already have gout may still need to monitor coffee intake, especially if they are sensitive to caffeine or have comorbid conditions (e.g., heart issues). The benefits are generally observed with long-term consumption rather than short-term effects.

Multiple sclerosis (MS)

Two recent reviews explored the link between caffeine and multiple sclerosis (MS), yielding distinct insights. One systematic review of eight studies found no clear connection between caffeine intake and MS-related disability, though it hinted at possible cognitive benefits for patients (83). In contrast, a meta-analysis of 10 observational studies involving over 19,000 participants reported that coffee consumption may lower the risk of developing MS, even after adjusting for confounding factors (84). Both studies emphasise the need for more rigorous, prospective research to clarify caffeine’s role in MS prevention and management.

Suicide

In a meta-analysis involving 17 studies consuming more than 60 cups of coffee monthly was associated with a decreased risk of suicide attempts (85).

Age-related macular degeneration

Caffeine consumption, particularly from tea, may help slow the progression of age-related macular degeneration, though its role in preventing disease onset remains uncertain (86).

Gastrointestinal diseases

Unsweetened coffee consumption, especially 2–4 cups per day, is linked to a lower risk of gastrointestinal diseases, while sweetened varieties show limited or inconsistent benefits (87). A meta-analysis of 21 studies with over 13,000 participants found no overall link between caffeine intake and IBD risk, but highlighted important subgroup differences (88). Coffee and tea consumption reduced ulcerative colitis risk in Asia and Europe, while caffeine increased risk among Americans, adolescents, and smokers, showing that age, region and lifestyle factors strongly influence outcomes (88).

Health risks⚠️

Appetite and weight 🍽️ 🤤 ⚖️

Coffee’s influence on appetite and body weight is complex, involving both behavioural and metabolic pathways. Studies have explored its effects on food preferences, hormonal responses and adipose tissue remodelling.

A pilot crossover randomised trial investigated the effects of coffee intake on appetite parameters in women with overweight or obesity (89). Results indicated that coffee consumption increased the desire for sweet foods, fructose intake and triglyceride levels, but showed no changes in ghrelin or cholecystokinin levels, suggesting coffee may influence appetite and dietary behaviour through sensory-specific desire (89). A systematic review and meta-analysis of cross-sectional studies found no overall association between coffee consumption and general or abdominal obesity, but a positive link was observed between coffee intake and general obesity in women (90). A recent study showed that coffee consumption in rats fed a high-fat diet modulated adipose tissue remodelling by influencing thermogenic, lipogenic and angiogenic gene expression across brown, inguinal and epididymal fat depots (91). These findings suggest that coffee may counteract diet-induced obesity through enhanced energy metabolism and reduced lipid accumulation in adipose tissue.

Sleep🌙

High caffeine intake, especially late in the day, can disrupt sleep patterns and contribute to insomnia. A randomised clinical crossover trial investigated the effects of caffeine dose and timing on sleep (92). A 100 mg dose had no impact on sleep, while a 400 mg dose disrupted sleep initiation, architecture and quality, particularly when consumed within 12 hours of bedtime (92). Sleep fragmentation increased with 400 mg taken eight hours prior and perceived sleep quality worsened when consumed four hours before bedtime, highlighting the potential disconnect between subjective and objective sleep assessments (92).

Digestive health

Coffee is widely consumed and often scrutinised for its impact on gastrointestinal (GI) health (93). While popular belief and anecdotal reports suggest it may aggravate certain digestive conditions, scientific evidence paints a more nuanced picture (93).

Coffee has distinct effects on GI function—most notably, it promotes gastroesophageal reflux and stimulates colonic and gallbladder activity (93). However, it is not a proven cause of dyspepsia and its physiological effects extend beyond caffeine alone (93). While coffee is frequently suspected to trigger gastroesophageal reflux disease (GERD) symptoms, a meta-analysis found no consistent association between coffee intake and GERD overall—except in cases diagnosed via endoscopy, where a modest increase in risk was observed (94). Additionally, in a cross-sectional study of 1,669 patients, coffee consumption (including total intake and specific subtypes) was not associated with an increased risk of colonic diverticulosis (95).

Coffee intake during pregnancy and lactation

Caffeine and coffee consumption during pregnancy increased the risk of pregnancy loss, with a dose–response relationship showing higher risk with greater intake (96, 97). Additionally, individuals harbouring the MTHFR 677 gene variants who have an inherited risk of miscarriage/spontaneous abortion (98) may metabolise caffeine less efficiently, potentially heightening susceptibility to adverse pregnancy outcomes when combined with high caffeine intake. However, studies investigating both MTHFR and coffee intake during pregnancy are needed to confirm. Furthermore, high maternal caffeine intake, especially from coffee, has been associated with adverse effects on foetal development, including low birth weight and preterm birth (99). While continuous maternal tea consumption during the second and third trimesters was positively linked to children's cognitive and motor development, no benefit was observed with coffee intake. Maternal coffee intake is also associated with an increased risk of childhood acute leukaemia, particularly acute lymphoid leukaemia (ALL) (100). A prospective birth Korean study linked maternal coffee intake to a lower risk of certain allergic diseases in children up to 36 months, particularly atopic dermatitis and food allergy, while no associations were found for asthma or allergic rhinitis (101). Mild intake (<1 serving/day) showed modest protective effects and higher intake (≥1 serving/day) was associated with reduced food allergy risk (101).

Lactation is a critical phase for maternal and infant health. Coffee consumption—particularly caffeine—may influence hormonal and physiological aspects of breastfeeding, including caffeine transfer into breast milk and its potential effects on infants (102). While current guidelines emphasise moderation, further research is needed to establish clearer recommendations for caffeine intake during lactation.

Hearing loss🦻🛑

A study examined the link between dietary caffeine intake and two types of hearing loss (HL) (i.e. speech-frequency hearing loss (SFHL) and high-frequency hearing loss (HFHL)) using data from 6,082 participants in the National Health and Nutrition Examination Survey (103). Results show that individuals with higher caffeine intake had higher rates of both SFHL and HFHL (103). After adjusting for confounders, high caffeine intake remained associated with SFHL but not HFHL (103). The association was stronger in participants under 65 years, with no link in older adults (103). This suggests that high caffeine consumption may increase the risk of SFHL, particularly in younger adults (103).

Osteoarthritis 🦴🦵⚡

Data from the National Health and Nutrition Examination Survey and Mendelian randomisation was used by researchers to investigate the link between coffee consumption and osteoarthritis (OA) (104). Findings showed that higher coffee intake, particularly over 4 cups per day, is associated with an increased risk of OA, especially knee and hip OA, suggesting a potential causal relationship (104).

Anaemia 🩸

Coffee (including decaf versions) contains polyphenols (tannins and chlorogenic acids) that can inhibit the absorption of non-haeme iron, especially when consumed close to meals (105). This effect may increase the risk of iron deficiency anaemia, particularly in individuals already vulnerable to low iron levels. Iron absorption can be reduced by up to 60% when coffee is consumed within an hour of a meal (106). Improper coffee habits may raise anaemia risk by 2.91 times (107).

Caffeine use disorder ☕⚡😵

Caffeine use disorder is characterised by a problematic pattern of caffeine consumption that causes significant distress or impairment (108, 109). According to the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (Caffeine Use Disorder DSM-5 - Therapedia), it is defined by the presence of three or more of the following within a 12-month period:

·        A persistent desire or repeated failed attempts to control caffeine use.

·        Continued intake despite physical or mental health issues due to use (disrupts sleep or contributes to anxiety).

·        Withdrawal effects—such as headaches, tiredness, low mood and irritability—when reducing or stopping caffeine.

Up to 30% of caffeine users may meet the criteria for the disorder (109). Caffeine use disorder can lead to caffeine toxicity (around 1 to 1.5 grams per day), known as caffeinism, characterised by restlessness, anxiety, sleep disturbances and digestive issues (110). Tapering off caffeine gradually is advised to manage withdrawal.

Coffee intake recommendations ☕📏✅

Coffee intake should be carefully tailored to age and individual health needs. For children and adolescents, caffeine should be avoided or strictly limited due to its potential impact on sleep, growth, mood and cognitive development. Health authorities recommend a maximum of 2.5 mg of caffeine per kilogram of body weight per day for children—a limit often reached through soft drinks and chocolate alone, making coffee unsuitable for this age group. Adults, however, may benefit from moderate coffee consumption, with 3–4 cups per day linked to reduced risk of certain chronic diseases as discussed above. Genetic differences in caffeine metabolism can make some individuals more sensitive to coffee, requiring less than the typical 3–4 cup daily recommendation. Drinking coffee earlier in the day is preferable to avoid sleep disruption and choosing paper-filtered brews can help reduce cholesterol-raising compounds.

To maximise health benefits, coffee should be consumed mindfully. Excessive additives such as sugar and artificial creamers can undermine its positive effects, and individuals with specific health concerns—such as pregnancy, anxiety, acute gout or hypertension—should moderate their intake. Adding milk may support bone health but aggravate anaemia risk and reduces antioxidant activity. While coffee contributes to hydration, it should not replace water as the primary fluid source. Overall, coffee can be a healthful beverage when consumed with awareness of timing, preparation and personal health factors.

Conclusion☕

Coffee consumption, like any dietary habit, presents both benefits and considerations. For most healthy adults, moderate intake—particularly in the morning and without excessive additives—is generally associated with positive or neutral health outcomes. Current evidence indicates potential protective effects against liver disease, neurodegenerative diseases, type 2 diabetes and cardiovascular conditions. However, factors such as preparation method, timing of consumption and overall quantity can influence its impact on sleep quality and health.

The evolving body of research underscores a shift in nutritional science toward personalised, context-sensitive recommendations. Coffee is neither a panacea nor a universal risk; rather, it is a culturally embedded practice that, when consumed thoughtfully, may support overall well-being. As such, individuals are encouraged to reflect not only on what they consume, but also on how, when and why—recognising that informed choices can enhance the health benefits of this widely enjoyed beverage.

Reflections on coffee intake ☕🔄💭

⚖️ Is my coffee consumption affecting my health? Have I noticed symptoms such as anxiety, insomnia, acid reflux, or increased heart rate that might be linked to caffeine?

🧘 Could I benefit from mindful coffee habits? Would spacing out my cups, choosing smaller servings, or switching to decaf in the afternoon help me feel more balanced?

⏳ Have I considered the long-term impact? Is my coffee intake sustainable for my body, especially as I age or if I develop health conditions that require moderation?

Love what you’re reading? Share the knowledge! 📨 Forward this link to a friend who might also enjoy it.

References 📚

1.           Reyes CM, Cornelis MC. Caffeine in the Diet: Country-Level Consumption and Guidelines. Nutrients. 2018;10(11).

2.           Landais E, Moskal A, Mullee A, Nicolas G, Gunter MJ, Huybrechts I, et al. Coffee and Tea Consumption and the Contribution of Their Added Ingredients to Total Energy and Nutrient Intakes in 10 European Countries: Benchmark Data from the Late 1990s. Nutrients. 2018;10(6).

3.           Antoniak MA, Szymkowiak A, Borusiak B, Borović D, Mesić Ž. Beyond Caffeine: Psychological Motives Behind Coffee Consumption Intensity and Frequency. Coffee And Tea Marketing Journal. 2025;2(1):9-22.

4.           Poole R, Kennedy OJ, Roderick P, Fallowfield JA, Hayes PC, Parkes J. Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes. bmj. 2017;359.

5.           Fulton JL, Dinas PC, Carrillo AE, Edsall JR, Ryan EJ, Ryan EJ. Impact of Genetic Variability on Physiological Responses to Caffeine in Humans: A Systematic Review. Nutrients. 2018;10(10).

6.           Alsene K, Deckert J, Sand P, de Wit H. Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology. 2003;28(9):1694-702.

7.           Jamil S, Raza ML, Naqvi S, Zehra A. Behavioral and psychological aspects of coffee consumption. Progress in Brain Research. 2024;289:151-68.

8.           Simões MBA, Brandão JM, Antunes ABS, Sichieri R. Coffee Intake in Brazil Influences the Consumption of Sugar, Sweets, and Beverages. Nutrients. 2024;16(23):4019.

9.           Rehm CD, Ratliff JC, Riedt CS, Drewnowski A. Coffee Consumption among Adults in the United States by Demographic Variables and Purchase Location: Analyses of NHANES 2011–2016 Data. Nutrients. 2020;12(8):2463.

10.        Li J, Yu K, Bu F, Li P, Hao L. Exploring the impact of coffee consumption and caffeine intake on cognitive performance in older adults: a comprehensive analysis using NHANES data and gene correlation analysis. Nutrition Journal. 2025;24:102.

11.        Southward K, Rutherfurd-Markwick KJ, Ali A. The Effect of Acute Caffeine Ingestion on Endurance Performance: A Systematic Review and Meta–Analysis. Sports Medicine. 2018;48(8):1913-28.

12.        Montalvo-Alonso JJ, Del Val-Manzano M, Cerezo-Telléz E, Ferragut C, Valadés D, Rodríguez-Falces J, et al. Acute caffeine intake improves muscular strength, power, and endurance performance, reversing the time-of-day effect regardless of muscle activation level in resistance-trained males: a randomized controlled trial. Eur J Appl Physiol. 2025.

13.        Chen B, Zhang C, Xu Z, Li Y, Guo L, Cao Y, et al. Effects of Caffeine Supplementation on Exercise Performance in Volleyball Players: A Systematic Review and Meta-Analysis. Nutrients. 2025;17(10).

14.        Bougrine H, Paillard T, Jebabli N, Ceylan H, Maitre J, Dergaa I, et al. Ergogenic Effects of Combined Caffeine Supplementation and Motivational Music on Anaerobic Performance in Female Handball Players: A Randomized Double-Blind Controlled Trial. Nutrients. 2025;17(10).

15.        Wang J, Dewi L, Peng Y, Hou C-W, Song Y, Condello G. Does ergogenic effect of caffeine supplementation depend on CYP1A2 genotypes? A systematic review with meta-analysis. Journal of Sport and Health Science. 2024;13(4):499-508.

16.        Richardson DL, Hill M, Tallis J, Ferreira LG, Clarke ND. The acute effects of coffee ingestion on postural control and physical function in older adults: A randomised crossover trial. Exp Gerontol. 2024;197:112592.

17.        Konidari Z, Smilios I, Mougios V, Bogdanis GC. Effects of an Acute High Dose of Caffeine on Physiological Responses and Performance During a Strength-Focused CrossFit(®) Workout: A Randomized, Double-Blind, Crossover Study. Nutrients. 2025;17(9).

18.        Pernigoni M, Cesanelli L, Šimkus L, Shah H, Gorbas J, Coletta F, et al. Boost or bust? A randomized crossover study on pre-exercise caffeine supplementation for fatigue management in basketball. Nutrition. 2025;139:112855.

19.        Xiao Y, Ding L, Xu Z, Liu J, Guo L, Barnes MJ, et al. Effects of acute caffeine intake on muscular power during resistance exercise: a systematic review and meta-analysis. Frontiers in Nutrition. 2025;Volume 12 - 2025.

20.        Papadakis Z, Panoutsakopoulos V, Schwarz A, Antonio J. Caffeine's influence on vertical jump height: a real-life collegiate student-athlete approach. J Int Soc Sports Nutr. 2025;22(1):2501063.

21.        Shabir A, Hooton A, Tallis J, M FH. The Influence of Caffeine Expectancies on Sport, Exercise, and Cognitive Performance. Nutrients. 2018;10(10).

22.        Montalvo-Alonso JJ, Del Val-Manzano M, Martín-Rivas I, Ferragut C, Valadés D, Pérez-López A. CYP1A2 Genotype and the Ergogenic Effect of Acute Caffeine Intake on Muscular Strength and Endurance Performance in Trained Individuals. Scand J Med Sci Sports. 2026;36(2):e70214.

23.        Zhou B, Ruan M, Pan Y, Wang L, Zhang FF. Coffee Consumption and Mortality Among U.S. Adults: A Prospective Cohort Study. The Journal of Nutrition. 2025.

24.        Wang X, Ma H, Sun Q, Li J, Heianza Y, Van Dam RM, et al. Coffee drinking timing and mortality in US adults. European Heart Journal. 2025;46(8):749-59.

25.        Watanabe D, Yoshida T, Nanri H, Watanabe Y, Yamada Y, Kimura M. Association of caffeine, green tea and coffee consumption with mortality and disability among older adults. The British journal of nutrition. 2025;134(9):755-63.

26.        Shang F, Li X, Jiang X. Coffee consumption and risk of the metabolic syndrome: A meta-analysis. Diabetes & metabolism. 2016;42(2):80-7.

27.        Kim S, Shin D. Causal effect of coffee consumption on metabolic syndrome in Korean adults: a 2-sample Mendelian randomization study. Nutr Res Pract. 2025;19(6):943-66.

28.        Bhupathiraju SN, Pan A, Manson JE, Willett WC, van Dam RM, Hu FB. Changes in coffee intake and subsequent risk of type 2 diabetes: three large cohorts of US men and women. Diabetologia. 2014;57(7):1346-54.

29.        Rao Y, Yu EY-W, Lin T-Y, Chen Y, Qin Y, Koster A, et al. Interaction between coffee consumption and polygenic risk score in relation to diabetes: insights from the Maastricht study. European Journal of Nutrition. 2025;64(6):1-13.

30.        Xiong K, Gao T. Association between daily coffee intake and diabetic kidney disease: evidence from the 2007 to 2016 NHANES. Int Urol Nephrol. 2025.

31.        Zang Q, Song Z, Zhang X, Ding M, Yan M, Li D, et al. Timing and dose matter: a diurnal pattern of coffee consumption optimises improvement in insulin resistance. Archives of Medical Science. 2025.

32.        Kuo P-Y, Geng J-H, Wu P-Y, Huang J-C, Chen S-C. Associations Between Coffee Consumption and the Prevalence of Metabolic Syndrome: A Nationwide Cross-Sectional Survey of Taiwanese Adults. Nutrients. 2026;18(3):463.

33.        Choi S, Park T, Je Y. Association Between Coffee Consumption and Glucose Metabolism Markers in Korean Adults. Nutrients. 2025;17(9):1484.

34.        Rayo-Mendez LM, Kinzer C, McMahon J, Nguyen M, Harris GK. Coffee Roast Level, Timing, and Carbohydrate Source Affect Peak Blood Glucose and Area Under the Curve Values in a Randomized Pilot Clinical Trial. J Nutr Metab. 2025;2025:4174563.

35.        Mohamed AI, Erukanure OL, Ismail H, Islam MS. Coffee improves the antidiabetic and hepatoprotective activities of metformin: an in vitro, ex vivo, and computational study. International Journal of Food Science and Technology. 2025:vvaf110.

36.        Mo C, Duan X, Pu J, Zhou X, Zheng Y, Wang S. Coffee Consumption as a Double-Edged Sword for Serum Lipid Profile: Findings from NHANES 2005-2020. Frontiers in Nutrition.12:1606188.

37.        Natella F, Nardini M, Belelli F, Pignatelli P, Di Santo S, Ghiselli A, et al. Effect of coffee drinking on platelets: inhibition of aggregation and phenols incorporation. British journal of nutrition. 2008;100(6):1276-82.

38.        Roach RE, Siegerink B, le Cessie S, Rosendaal FR, Cannegieter SC, Lijfering WM. Coffee consumption is associated with a reduced risk of venous thrombosis that is mediated through hemostatic factor levels. J Thromb Haemost. 2012;10(12):2519-25.

39.        Papamichael CM, Aznaouridis KA, Karatzis EN, Karatzi KN, Stamatelopoulos KS, Vamvakou G, et al. Effect of coffee on endothelial function in healthy subjects: the role of caffeine. Clin Sci (Lond). 2005;109(1):55-60.

40.        Dludla PV, Cirilli I, Marcheggiani F, Silvestri S, Orlando P, Muvhulawa N, et al. Potential benefits of coffee consumption on improving biomarkers of oxidative stress and inflammation in healthy individuals and those at increased risk of cardiovascular disease. Molecules. 2023;28(18):6440.

41.        Choi S, Je Y. Coffee consumption and C-reactive protein levels: A systematic review and meta-analysis. Nutrition, Metabolism and Cardiovascular Diseases. 2024;34(11):2425-39.

42.        Han S, Qiu Y, Zhang GQ, Lian F, Zhang W. A meta-analysis and systematic review of randomized clinical trials on the effect of coffee consumption on heart rate. Nutrition Reviews. 2023;82(8):1046-55.

43.        Elsahoryi NA, Ibrahim MO, Alhaj OA, Hammouh F. Acute Cardiovascular Effects of Turkish Coffee Assessed by VO(2) Test: A Randomized Crossover Trial. Nutrients. 2025;17(5).

44.        Nijssen KMR, Mensink RP, Joris PJ. Effects of Coffee-Related Bioactive Components on Flow-Mediated Vasodilation: A Meta-Analysis of Randomized, Controlled Intervention Studies in Adults. Nutrition Reviews. 2025.

45.        Qiao X, Toma VW, Wang J, Herraiz-Adillo Á, Söderholm S, Berglind D, et al. Genetic predisposition to coffee consumption and the association with the early risk of atherosclerosis. Scientific Reports. 2026.

46.        Haghighatdoost F, Hajihashemi P, de Sousa Romeiro AM, Mohammadifard N, Sarrafzadegan N, de Oliveira C, et al. Coffee Consumption and Risk of Hypertension in Adults: Systematic Review and Meta-Analysis. Nutrients. 2023;15(13):3060.

47.        Bhandari B, Zeng L, Grafenauer S, Schutte AE, Xu X. Long-term consumption of six different beverages and cardiovascular mortality: a systematic review and meta-analysis of prospective cohort studies. Current Developments in Nutrition. 2024:102095.

48.        Gill H, Patel N, Naik N, Vala L, Rana RK, Jain S, et al. An umbrella review of meta-analysis to understand the effect of coffee consumption and the relationship between stroke, cardiovascular heart disease, and dementia among its global users. Journal of Family Medicine and Primary Care. 2024;13(11).

49.        Ding L, Wang H-P, Zhao J-Y, Zhao X, Sha Y, Qin L-Q, et al. Coffee and tea consumption and cardiovascular disease and all-cause and cause-specific mortality in individuals with diabetes mellitus: a meta-analysis of prospective observational studies. Frontiers in Nutrition. 2025;Volume 12 - 2025.

50.        Yang D, Mao Y, Chen S, Lin W, Li L, Liang J, et al. Effect of different types of coffee consumption on the risk of cardiovascular complications and related mortality events in prediabetes: an analysis from NHANES. Nutrition, Metabolism and Cardiovascular Diseases. 2025:104113.

51.        Olsen MM, Brækkan SK, Hveem K, Grønning K, Hansen J-B. Repeated Measures of Coffee Consumption and Risk of Future Incident Venous Thromboembolism–the HUNT and Tromsø studies. Research and Practice in Thrombosis and Haemostasis. 2025.

52.        Wong CX, Cheung CC, Montenegro G, Oo HH, Peña IJ, Tang JJ, et al. Caffeinated Coffee Consumption or Abstinence to Reduce Atrial Fibrillation: The DECAF Randomized Clinical Trial. Jama. 2025.

53.        Alves M, Dragovic F, Correia C, Rodrigues T, Oliveira MR, Caldeira D, et al. The Impact of Coffee Consumption on Mortality Among Patients With Heart Failure. Cureus. 2026;18(2).

54.        Yu X, Bao Z, Zou J, Dong J. Coffee consumption and risk of cancers: a meta-analysis of cohort studies. BMC Cancer. 2011;11(1):96.

55.        Giovannucci E. Meta-analysis of Coffee Consumption and Risk of Colorectal Cancer. American journal of epidemiology. 1998;147(11):1043-52.

56.        Larsson SC, Wolk A. Coffee Consumption and Risk of Liver Cancer: A Meta-Analysis. Gastroenterology. 2007;132(5):1740-5.

57.        Bai K, Cai Q, Jiang Y, Lv L. Coffee consumption and risk of hepatocellular carcinoma: a meta-analysis of eleven epidemiological studies. OncoTargets and therapy. 2016:4369-75.

58.        Choi HB, Kim H, Yoo JJ, Kim SG, Kim YS. Coffee and the Risk of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Mendelian Randomization Studies. Gut Liver. 2026;20(1):153-7.

59.        Romelli M, Gnagnarella P, Gaeta A, Serrano D, Ermini I, Cavalcabo NDB, et al. Coffee and tea intake and survival of cancer patients: a systematic review and meta-analysis. Cancer Causes Control. 2025.

60.        Karimi M, Shahir-Roudi E, Shokoohy F, Kazemi K, Aghayan AH, Rostami Varnosfaderani M, et al. Coffee consumption and risk of thyroid cancer: a systematic review and meta-analysis of cohort and case control studies. Thyroid Research. 2025;18(1):60.

61.        Jabbari M, Salari-Moghaddam A, Bagheri A, Larijani B, Esmaillzadeh A. A systematic review and dose–response meta-analysis of prospective cohort studies on coffee consumption and risk of lung cancer. Scientific Reports. 2024;14(1):14991.

62.        Inoue-Choi M, Ramirez Y, O'Connell C, Berrington de Gonzalez A, Dawsey SM, Abnet CC, et al. Hot beverage intake and oesophageal cancer in the UK Biobank: prospective cohort study. Br J Cancer. 2025;132(7):652-9.

63.        Alqutub A, Awadh MA, Alsulami OA, Alalhareth MH, Mozahim NF, Hakami M, et al. Coffee consumption and head and neck cancer risk: a dose–response and site-specific meta-analysis. European Journal of Cancer Prevention. 9900.

64.        Kennedy OJ, Roderick P, Buchanan R, Fallowfield JA, Hayes PC, Parkes J. Systematic review with meta-analysis: coffee consumption and the risk of cirrhosis. Alimentary Pharmacology & Therapeutics. 2016;43(5):562-74.

65.        Bacil GP, Romualdo GR, Barbisan LF. Protective Effects of Coffee on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Potential Interplay with the Gut Microbiome. In: Banach M, Surma S, editors. The Link Between Coffee and Health. Cham: Springer Nature Switzerland; 2025. p. 367-89.

66.        Liu W, Xu X, Chang Q, Yang H, Ma Z, Zhang T, et al. Different types of sweetened coffee consumption, genetic predictor of gut microbe, and the risk of metabolic dysfunction-associated steatotic liver disease. Nutrition Journal. 2026;25(1):31.

67.        Li W, Xie Y, Jiang L. Coffee and tea consumption on the risk of osteoporosis: a meta-analysis. Frontiers in Nutrition. 2025;Volume 12 - 2025.

68.        Rapuri PB, Gallagher JC, Kinyamu HK, Ryschon KL. Caffeine intake increases the rate of bone loss in elderly women and interacts with vitamin D receptor genotypes1234. The American Journal of Clinical Nutrition. 2001;74(5):694-700.

69.        Zhang T, Song J, Shen Z, Yin K, Yang F, Yang H, et al. Associations between different coffee types, neurodegenerative diseases, and related mortality: findings from a large prospective cohort study. The American Journal of Clinical Nutrition. 2024;120(4):918-26.

70.        Johal K, Jones DJW, Bell L, Lovegrove JA, Lamport DJ. Impact of coffee-derived chlorogenic acid on cognition: a systematic review and meta-analysis. Nutrition Research Reviews. 2025;38(1):393-406.

71.        Ashfaq Z, Younas Z, Nathaniel E, Rehman A, Siddiqi A, Rasool N, et al. Association Between Caffeine Intake and Alzheimer's Disease Progression: A Systematic Review. Cureus. 2025;17(3):e80923.

72.        Zhang Y, Liu Y, Li Y, Li Y, Gu X, Kang JH, et al. Coffee and Tea Intake, Dementia Risk, and Cognitive Function. Jama. 2026.

73.        Choi HK, Willett W, Curhan G. Coffee consumption and risk of incident gout in men: a prospective study. Arthritis Rheum. 2007;56(6):2049-55.

74.        Choi HK, Curhan G. Coffee consumption and risk of incident gout in women: the Nurses' Health Study. Am J Clin Nutr. 2010;92(4):922-7.

75.        Larsson SC, Carlström M. Coffee consumption and gout: a Mendelian randomisation study. Annals of the Rheumatic Diseases. 2018;77(10):1544-6.

76.        Lee YH. Coffee consumption and gout: a Mendelian randomisation study. Annals of the rheumatic diseases. 2019;78(11):e130-e.

77.        Towiwat P, Tangsumranjit A, Ingkaninan K, Jampachaisri K, Chaichamnong N, Buttham B, et al. Effect of caffeinated and decaffeinated coffee on serum uric acid and uric acid clearance, a randomised within-subject experimental study. Clin Exp Rheumatol. 2021;39(5):1003-10.

78.        Moon SM, Joo MJ, Lee YS, Kim MG. Effects of Coffee Consumption on Insulin Resistance and Sensitivity: A Meta-Analysis. Nutrients. 2021;13(11).

79.        Toyoki D, Shibata S, Kuribayashi-Okuma E, Xu N, Ishizawa K, Hosoyamada M, et al. Insulin stimulates uric acid reabsorption via regulating urate transporter 1 and ATP-binding cassette subfamily G member 2. American Journal of Physiology-Renal Physiology. 2017;313(3):F826-F34.

80.        Zhang Y, Cui Y, Li X-a, Li L-j, Xie X, Huang Y-z, et al. Is tea consumption associated with the serum uric acid level, hyperuricemia or the risk of gout? A systematic review and meta-analysis. BMC Musculoskeletal Disorders. 2017;18(1):95.

81.        Flavin D. Metabolic danger of high-fructose corn syrup. Life Extension. 2008.

82.        Angelopoulos TJ, Lowndes J, Zukley L, Melanson KJ, Nguyen V, Huffman A, et al. The Effect of High-Fructose Corn Syrup Consumption on Triglycerides and Uric Acid12. The Journal of Nutrition. 2009;139(6):1242S-5S.

83.        Salekzamani S, Baharomid S, Pakkhesal S, Balafkandeh M, Gholipour-Khalili E, Talebi M, et al. The Effects of Coffee/Caffeine in Patients with Multiple Sclerosis; A Systematic Review. J Evid Based Integr Med. 2024;29:2515690x241293114.

84.        Amirnia M, Raeisnia K, Ashayeri H, Hakimzadeh Z, Nasiri E, Talebi M, et al. Coffee consumption and risk of multiple sclerosis: A systematic review and meta-analysis. Autoimmun Rev. 2025;24(7):103822.

85.        Low CE, Chew NSM, Loke S, Tan JY, Phee S, Lee A, et al. Association of Coffee and Energy Drink Intake with Suicide Attempts and Suicide Ideation: A Systematic Review and Meta-Analysis. Nutrients. 2025;17(11).

86.        Electra J, Theodoraliu E, Lazarus G, Lestari YD, Djatikusumo A. The effect of caffeine consumption on age-related macular degeneration: a systematic review and meta-analysis. Int Ophthalmol. 2025;45(1):158.

87.        Zhou S, Hu F, Long Z, Huang H, Li D, Chu M, et al. Coffee Consumption and Risk of Incident Gastrointestinal Disease: A Large Prospective Cohort Study. Food Sci Nutr. 2025;13(12):e71271.

88.        Wu X, Jiang J, Lu Q. Caffeine and IBD Risk: A Meta-Analysis. J Gastroenterol Hepatol. 2025.

89.        Magaña-de la Vega L, Martínez-López E, Sanchez-Murguia T, Madrigal-Juárez A, Rodríguez-Reyes SC, Aguilar-Vega I, et al. Effect of coffee intake on appetite parameters in woman with overweight or obesity: A pilot crossover randomized trial. Endocrinología, Diabetes y Nutrición. 2024.

90.        Nemati M, Soltani S, Almasi F, Salari-Moghaddam A, Larijani B, Ebrahimzadeh A, et al. Coffee Consumption, General Obesity and Abdominal Obesity in Adults: A Systematic Review and Meta-Analysis of Cross-Sectional Studies. Adv Biomed Res. 2024;13:122.

91.        Cavalcanti MH, da Costa THM, Damazo AS, Arruda SF. Coffee consumption affects adipose tissue remodeling in a high-fat diet-induced obesity model by different mechanisms in rats. bioRxiv. 2025:2025.07. 18.665488.

92.        Gardiner CL, Weakley J, Burke LM, Fernandez F, Johnston RD, Leota J, et al. Dose and timing effects of caffeine on subsequent sleep: A randomised clinical crossover trial. Sleep. 2024.

93.        J. Boekema MSGPvBHAJPMSP. Coffee and Gastrointestinal Function: Facts and Fiction: A Review. Scandinavian Journal of Gastroenterology. 1999;34(230):35-9.

94.        Kim J, Oh S-W, Myung S-K, Kwon H, Lee C, Yun JM, et al. Association between coffee intake and gastroesophageal reflux disease: a meta-analysis. Diseases of the Esophagus. 2014;27(4):311-7.

95.        Buldukoglu OC, Ocal S, Akca S, Atar GE, Harmandar FA, Cekin AH. Relationship of coffee consumption with colonic diverticulosis. BMC Gastroenterology. 2025;25(1):548.

96.        Li J, Zhao H, Song J-M, Zhang J, Tang Y-L, Xin C-M. A meta-analysis of risk of pregnancy loss and caffeine and coffee consumption during pregnancy. International Journal of Gynecology & Obstetrics. 2015;130(2):116-22.

97.        Ayoub A, Yaseen M. Relationship between caffeine or coffee consumption and Miscarriage: Findings from systematic review and meta-analysis. Journal of Health Informatics in Developing Countries. 2022;16(1).

98.        Du B, Shi X, Yin C, Feng X. Polymorphisms of methalenetetrahydrofolate reductase in recurrent pregnancy loss: an overview of systematic reviews and meta-analyses. Journal of Assisted Reproduction and Genetics. 2019;36(7):1315-28.

99.        Ouyang J, Wu P, Chen L, Tong J, Yan S, Li J, et al. Impact of tea and coffee consumption during pregnancy on children's cognitive development. Sci Rep. 2025;15(1):8832.

100.     Flores-García MK, Flores-Collado G, Mérida-Ortega Á, Ugalde-Resano R, González-Rocha A, Denova-Gutiérrez E, et al. Maternal and infant diet play a role in acute leukemia development: an expanded systematic review and meta-analysis. Clinical nutrition ESPEN. 2025.

101.     Afroz S, Cho S, Oh J, Kim JH, Kim SY, Ha E, et al. Maternal Coffee Consumption during Pregnancy and Risk of Allergic Diseases in Children: The Korean Children's Environmental Health Study. Healthc Inform Res. 2026;32(1):77-91.

102.     Kourampi I, Chodnekar SY. Coffee Consumption During Lactation. In: Banach M, Surma S, editors. The Link Between Coffee and Health. Cham: Springer Nature Switzerland; 2025. p. 321-31.

103.     Xia F, Ren Y. Association between caffeine intake from foods and beverages in the diet and hearing loss in United States adults. Front Neurol. 2024;15:1436238.

104.     Feng K, Li P, Guo H, Chen Z. The impact of coffee consumption on osteoarthritis: insights from NHANES and Mendelian randomization analysis. Front Nutr. 2024;11:1434704.

105.     Gunec CB. A mini review on the relationship between coffee and tea consumption and iron absorption in the gut–iron deficiency anemia. Japan Journal of Clinical & Medical Research SRC/JJCMR-156 DOI: doi org/1047363/JJCMR/2023 (3). 2023;145:2-3.

106.     Morck TA, Lynch SR, Cook J. Inhibition of food iron absorption by coffee. The American journal of clinical nutrition. 1983;37(3):416-20.

107.     Kumera G, Haile K, Abebe N, Marie T, Eshete T. Anemia and its association with coffee consumption and hookworm infection among pregnant women attending antenatal care at Debre Markos Referral Hospital, Northwest Ethiopia. PloS one. 2018;13(11):e0206880.

108.     Meredith SE, Juliano LM, Hughes JR, Griffiths RR. Caffeine use disorder: a comprehensive review and research agenda. Journal of caffeine research. 2013;3(3):114-30.

109.     Addicott MA. Caffeine use disorder: a review of the evidence and future implications. Current Addiction Reports. 2014;1(3):186-92.

110.     Jee HJ, Lee SG, Bormate KJ, Jung Y-S. Effect of Caffeine Consumption on the Risk for Neurological and Psychiatric Disorders: Sex Differences in Human. Nutrients. 2020;12(10):3080.

In developing this work, the author utilised ChatGPT-4 to assist with language editing.